Registry to evaluate psychiatric medications during pregnancy
Official title: National Pregnancy Registry for Psychiatric Medications
Run by Massachusetts General Hospital · NCT01246765 · Data updated 2026-11-12
This study is trying to see if using certain psychiatric medications during pregnancy is safe for both mothers and their babies.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 5000 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | November 2008 |
| Main results expected | December 2033 |
| Study ends | December 2033 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT01246765 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant women aged 18-45 who are currently taking psychiatric medications.
✕Probably not a fit
Women who have completed their pregnancy or are planning to become pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The National Pregnancy Registry for Psychiatric Medications aims to assess the safety of various psychiatric medications, including antidepressants and atypical antipsychotics, used by pregnant women. This observational study will systematically document medication exposure during pregnancy and evaluate the associated risks of congenital malformations and neonatal outcomes. By gathering comprehensive data, the registry seeks to provide clinicians with reliable information regarding the reproductive safety of these medications, which is currently limited. This initiative represents one of the largest hospital-based efforts to monitor pregnancy outcomes related to psychiatric medication use.
Why it matters
Potential benefit: If successful, this registry could provide critical insights into the safety of psychiatric medications during pregnancy, guiding treatment decisions for expectant mothers.
How similar studies have gone: While there have been smaller studies on medication safety during pregnancy, this registry represents a novel and comprehensive approach to systematically evaluate the risks associated with psychiatric medications.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women * Age 18-45 * Subjects will be willing to participate over the phone * Subjects will be able to provide informed consent Exclusion Criteria: * Women who have completed their pregnancy * Women who are planning to become pregnant * Women who are not taking any psychiatric medications and/or have no history of psychiatric illness
Where it's running
-
Massachusetts General Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Lee S Cohen, MD — Massachusetts General Hospital
- Study coordinator: Bryn Rediger
- Email: brediger@partners.org
- Phone: (617) 724-8020
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prenatal yoga to help with birth experience and body image
This study tests whether a prenatal yoga program can improve how pregnant women perceive traumatic birth, how they feel about their bodies, and their preferred delivery method.
-
Preventing abdominal stretch marks in expectant mothers with Stratamark
This program will try Stratamark on pregnant women to see if applying it to the abdomen prevents stretch marks during pregnancy and after birth.
-
Oral health knowledge in pregnant women: does a one-time information leaflet help?
A one-time printed leaflet is tested to see if it improves oral health knowledge in pregnant women attending Hospital La Fe.
-
Outpatient induction of labour with a double‑balloon transcervical catheter for low‑risk pregnant women
This trial will test whether starting cervical ripening at home with a double‑balloon catheter is as safe, acceptable, and time‑efficient as staying in hospital for low‑risk pregnant women due for induction of labour.
-
Using placental blood markers to detect fetal stress during labor
This study will test whether levels of placental markers (sFlt-1, PlGF, and their ratio) can help predict which pregnant people (≥32 weeks) may experience fetal distress during labor.
-
How ultrafine particles and micro‑nano plastics affect fetal development
This project will test whether pregnant women’s exposure to ultrafine particulate matter and micro‑nano plastics increases the chance of preterm birth and later non‑communicable diseases in their children.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.